Stockreport

Analysts Have Made A Financial Statement On Foghorn Therapeutics Inc.'s (NASDAQ:FHTX) Third-Quarter Report [Yahoo! Finance]

Foghorn Therapeutics Inc.  (FHTX) 
PDF The results overall were pretty good, with revenues of US$7.8m exceeding expectations and statutory losses coming in at justUS$0.31 per share, some 30% below what the an [Read more]